Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ossium Health, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Incyte Corporation
Abramson Cancer Center at Penn Medicine
Chengdu Zenitar Biomedical Technology Co., Ltd
Memorial Sloan Kettering Cancer Center
Prescient Therapeutics, Ltd.
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
City of Hope Medical Center
Seagen Inc.
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
Fondazione Italiana Linfomi - ETS